IPharma | Retatrutide 30mg - 1.5ml | Research Compound Peptide Pen

High-Strength Triple Receptor Metabolic Research Compound

Retatrutide is an investigational peptide studied for its multi-receptor activity across GLP-1, GIP, and glucagon pathways.

It is widely referenced in scientific research exploring complex metabolic signalling, energy regulation mechanisms, and multi-pathway peptide interactions within controlled laboratory environments.

Developed as a 30mg (1.5ml) research compound, this formulation is designed for laboratory investigation where receptor activity profiling and advanced metabolic peptide research are of interest.

🧪 Key Benefits – IPharma Retatrutide Research Compound Peptide 30mg (1.5ml Pen)

• Triple receptor research compound targeting GLP-1, GIP, and glucagon pathways
• Investigated in metabolic signalling and endocrine research models
• Of interest in multi-pathway peptide interaction studies
• 30mg (1.5ml) research formulation for controlled laboratory investigation
• Studied in advanced metabolic peptide research contexts
• Pre-filled pen format designed for consistent laboratory handling
• High-purity investigational formulation from IPharma
• Manufactured for stability, consistency, and research reliability

⚖️ DISCLAIMER

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.

This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.

Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.

By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.